Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

After tumor removal, the woman regained normal hormone levels, menstruated, and had a healthy baby.

These ovarian conditions cause high testosterone levels.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

A rare ovarian tumor was found in a young woman with a genetic fat disorder.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

The lump on a woman's scalp was a rare, potentially cancerous tumor from the hair follicle, not a common cyst.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Merkel cell increase is specific to certain skin diseases, not general skin growth.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

High S100B protein levels indicate poor survival in advanced melanoma.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Tamoxifen caused hair loss in a 52-year-old woman.

A 15-year-old female labrador had a large ovarian tumor removed.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.